IP Library Granted Patent US 11,813,609
Granted Patent B2
US 11,813,609 · App. 16/845,631 · Granted Nov 14, 2023

Microfluidic cartridge for molecular diagnosis

Inventors: Yann Marcy (Marseilles, FR); Marc Artigue (Noisy Sur Ecole, FR); Quentin Le Masne (Grenoble, FR); Kevin Marq (Boulogne-Billancourt, FR)
Assignee: Genewave SAS
B01L3/502715B01L3/50273B01L3/502738B01L9/527C12Q1/6844B01L2200/027B01L2200/16B01L2300/0654B01L2300/087B01L2300/0819B01L2300/0848B01L2300/0864B01L2300/0887B01L2400/0478B01L2400/0487B01L2400/065B01L2400/0622B01L2400/0638B01L2400/0644B01L2400/0655
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,813,609
App. No.
16/845,631
Granted
Nov 14, 2023
Kind
B2
Abstract

A microfluidic cartridge for detecting one nucleic acid of a sample, including a plurality of functional volumes split into functional areas and a fluidic network of microchannels. At least three functional areas are fluidly connected to a central distribution hub of fluids by one or more hub-connected microchannels, the central distribution hub being capable of pumping and injecting fluids from a first functional area to a second functional area by passing through the central distribution hub; and at least three valves of hub-connected microchannels are arranged so that the at least three valves are adapted to be actuated mechanically by a single external cam-driven actuator.

Claims (55)

1. A microfluidic cartridge configured to detect at least one nucleic acid of a sample, the microfluidic cartridge comprising:

a cartridge plate comprising a substrate having a first face and a second face;

a first film bonded to the first face of the substrate of the cartridge plate;

a cartridge body connected with the cartridge plate at the second face of the substrate of the cartridge plate;

one central distribution hub configured to pump, inject, and distribute fluids, the central distribution hub comprising a hub body and a plunger configured to slide in and out of the hub body to pump from or inject the fluids, the central distribution hub being disposed within the cartridge body and connected to the cartridge plate;

a plurality of chambers defined within the cartridge body or between the cartridge plate and one of the first film and a biochip, the plurality of chambers being configured to hold the fluids, the plurality of chambers including a first set of chambers;

a membrane configured to cover the first set of chambers;

a network of fluidic microchannels formed in the cartridge plate and comprising at least three hub-connected microchannels connected with the one central distribution hub, each chamber of the first set of chambers being fluidly connected to the one central distribution hub by a corresponding one of the hub-connected microchannels, the central distribution hub being configured to pump and inject the fluids from at least one chamber of the first set of chambers to at least another chamber of the first set of chambers; and

a plurality of valves, each located on a respective one of the fluidic microchannels, the valves being formed by the first film and a respective valve seat formed by a recess in the cartridge plate opposite the first film, the first film being configured to deform in relation to the cartridge plate to control distribution of the fluids between at least the first set of chambers,

wherein the central distribution hub is configured to be connected to a pressure system to cause the central distribution hub to pump, inject and distribute the fluids communicating with the plurality of chambers, and

wherein the plunger of the central distribution hub is configured to slide in and out of the hub body to pump from or inject the fluids in the chambers through the hub-connected microchannels.

2. The microfluidic cartridge according to claim 1 , wherein the first set of chambers is arranged around the central distribution hub.

3. The microfluidic cartridge according to claim 1 , wherein the network of fluidic microchannels further comprises non-hub-connected microchannels connecting at least one of the chambers to at least another one of the chambers.

4. The microfluidic cartridge according to claim 3 , wherein the plurality of chambers includes a second set of chambers, and

wherein the first film is configured to deform in relation to the cartridge plate to control distribution of the fluids between the first set of chambers and the second set of chambers connected to the non-hub-connected microchannels.

5. The microfluidic cartridge according to claim 3 , wherein the plurality of chambers includes a second set of chambers, and

wherein the first film is configured to deform in relation to the cartridge plate to control distribution of the fluids between the second set of chambers to one another, the second set of chambers being connected to the non-hub-connected microchannels.

6. The microfluidic cartridge according to claim 1 , wherein the plurality of chambers includes a second set of chambers, and

wherein two chambers of the second set of the chambers are directly fluidly connected to each other by one or more non-hub-connected microchannels.

7. The microfluidic cartridge according to claim 1 , wherein at least three of the valves are circularly arranged in the microfluidic cartridge.

8. The microfluidic cartridge according to claim 1 , wherein each of the hub-connected microchannels comprises one of the valves located at a chamber end of the respective hub-connected microchannel.

9. The microfluidic cartridge according to claim 1 , wherein the cartridge plate comprises a plurality of grooves flush with the first face or the second face and a plurality of through holes connecting the first face and the second face,

the first film is bonded on the first face of the substrate of the cartridge plate, the grooves flush with the first face being sealed by the first film to form the hub-connected microchannels, the first film being configured to be deformed by an external actuator,

the cartridge body is in contact with the cartridge plate on the second face of the substrate, the cartridge body comprising:

a lateral wall which extends from the second face of the substrate, and

a plurality of internal walls which define chambers of the first set of chambers, and

a cartridge cover that is configured to close the first set of chambers.

10. The microfluidic cartridge according to claim 9 , further comprising a second film bonded on the second face of the substrate of the cartridge plate, the plurality of grooves flush with the second face being sealed by the second film to form non-hub-connected microchannels.

11. The microfluidic cartridge according to claim 9 , further comprising a plurality of recessed cavities formed in the cartridge plate, the recessed cavities being made in the first face of the cartridge plate and extending from the first face toward the inside of the cartridge plate.

12. The microfluidic cartridge according to claim 1 , wherein the cartridge plate comprises

at least one recessed cavity formed in the substrate and extending from the first face, and

a micro-array slide-bonded on the first face of the substrate closing the at least one recessed cavity to form at least one detection chamber of the second plurality of chambers for nucleic acid analysis.

13. The microfluidic cartridge according to claim 1 , wherein the first set of chambers are containers configured to receive tubes containing a sample, reagent products, or a purification column.

14. The microfluidic cartridge according to claim 1 , wherein the central distribution hub further comprises a plunger seal configured to slide in and out of the hub body to pump from or inject fluids in the chambers through the hub-connected microchannels.

15. The microfluidic cartridge according to claim 14 , wherein the central distribution hub further comprises a plunger to which the plunger seal is attached, the plunger and the plunger seal forming a syringe of the central distribution hub.

16. A microfluidic cartridge system comprising:

a microfluidic cartridge configured to detect at least one nucleic acid of a sample, the microfluidic cartridge comprising:

a cartridge plate comprising a substrate having a first face and a second face,

a first film bonded to the first face of the substrate of the cartridge plate,

a cartridge body connected with the cartridge plate at the second face of the substrate of the cartridge plate,

one central distribution hub configured to pump, inject, and distribute fluids, the central distribution hub comprising a hub body and a plunger configured to slide in and out of the hub body to pump from or inject the fluids, the central distribution hub being disposed within the cartridge body and connected to the cartridge plate,

a plurality of chambers defined within the cartridge body or between the cartridge plate and one of the first film and a biochip, the plurality of chambers being configured to hold fluids, the plurality of chambers including a first set of chambers,

a membrane configured to cover the first set of chambers,

a network of fluidic microchannels formed in the cartridge plate and comprising at least three hub-connected microchannels connected with the one central distribution hub, each chamber of the first set of chambers being fluidly connected to the one central distribution hub by a corresponding one of the hub-connected microchannels, the central distribution hub being configured to pump and inject the fluids from at least one chamber of the first set of chambers to at least another chamber of the first set of chambers, and

a plurality of valves each located on a respective one of the fluidic microchannels, the valves being formed by the first film and a respective valve seat formed by a recess in the cartridge plate opposite the first film, the first film being configured to deform in relation to the cartridge plate to control distribution of the fluids between at least the first set of chambers; and

a docking station configured to receive the microfluidic cartridge, the docking station comprising a cam-driven actuator configured to mechanically actuate the valves of the hub-connected microchannels,

wherein the central distribution hub is configured to be connected to a pressure system to cause the central distribution hub to pump, inject and distribute the fluids communicating with the plurality of chambers, and

wherein the plunger of the central distribution hub is configured to slide in and out of the hub body to pump from or inject the fluids in the chambers through the hub-connected microchannels.

17. The microfluidic cartridge system according to claim 16 , wherein the microfluidic cartridge further comprises a microarray slide, and

the docking station further comprises:

an optical exciter configured to excite the microarray slide of the microfluidic cartridge,

an optical detector configured to optically detect an optical signal that is representative of said nucleic acid in the sample analyzed by the microfluidic cartridge, and

an actuator configured to actuate the valves.

18. The microfluidic cartridge system according to claim 17 , wherein the docking system further comprises a contact imager forming a compact readout optical system for detection of a presence of nucleic acids analyzed in the microfluidic cartridge.

19. The microfluidic cartridge system according to claim 17 , wherein the docking station further comprises a DNA melting system configured to achieve a DNA melting procedure at an end of hybridization to allow an increase in detection specificity.

Assignments (6)
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2026
From: MOBIDIAG OY
To: GEN-PROBE INCORPORATED
Reel/Frame 074227/0597 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2026
From: GENEWAVE
To: MOBIDIAG OY
Reel/Frame 075325/0966 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2024
From: MOBIDIAG OY
To: GEN-PROBE INCORPORATED
Reel/Frame 068400/0684 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2024
From: GENEWAVE SAS
To: MOBIDIAG OY
Reel/Frame 068788/0810 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2020
From: MARCY, YANN; ARTIGUE, MARC; LE MASNE, QUENTIN; MARQ, KEVIN
To: GENEWAVE
Reel/Frame 052366/0955 →
Priority Claims (1)
EP 13306643 · Nov 29, 2013 · regional
Continuity (2)
Continuation 15039860
Related Publication 20200238285A1 · Jul 30, 2020
Cited By (1)
US 12,275,009